Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_assertion type Assertion NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_head.
- NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_assertion description "[Either the FVL or prothrombin variant was found in 10% (95% confidence interval, 3%-22%) of patients with idiopathic PE compared with 13% (8%-20%) of nonidiopathic PE, 2% (5%-14%) of PE excluded, and 9% (5%-14%) of PE not suspected patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_provenance.
- NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_assertion evidence source_evidence_literature NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_provenance.
- NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_assertion SIO_000772 16574759 NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_provenance.
- NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_assertion wasDerivedFrom befree-20140225 NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_provenance.
- NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_assertion wasGeneratedBy ECO_0000203 NP209834.RAKHnU7-xkCLTIlEbb8yzEtJ-AjmpGKGPiwGXsX0zM7m8130_provenance.